Students of accounting and listeners from the conference call.
Stempel indicated that some of the 8 million was for the sale of stock and some was prepaid royalties. how much we can't say because this is ECD and EVERYTHING is secret even though this is a "material transaction" for accountancy and SEC disclosure purposes and will have to be broken out in the next 10Q. We went through this precise same veil of secrecy when Honda bought some Ovonic stock. God only knows why we are so secret.
For students of accounting, the stock sale transaction will be recorded as a debit to cash (i.e., an increase) and a credit to paid in capital (i.e., an increase) thus the double entry accounts balance and my masters in Business will not be recalled (yet!). Thusly, there is no income for the stock sale portion of the 8mm whether, and there seems to be some confusion here, it was the sale of OVONIC stock (as I remember) or the sale of ECD stock. If one assumes half and half on the allocation of the 8 million, then we have pegged a value of $160mm for all of Ovonic-- not bad for a majority parent with a sub-$100 mm market cap. For whomever said they might have bought stock at a premium to intrinsic value: a)this makes no difference on the accounting, and b) I think they bought stock in Ovonic, so there is no readily ascertainable market value (only these FANTASTIC periodic sales to knowledgeable industry players.)
As to whether any of the royalty is refundable and how it would book, we will need the input of learned license sages like Mike Latas, or Prof. of Esoteric Documents-- Retiarius. After they bless the business dealings of this press release, floundering students of accountancy ought to be able to tell you how it books. |
